An Interplay between Obesity and Inflammation in Gestational Diabetes Mellitus

Author(s): Katarzyna E. Skórzyńska-Dziduszko, Żaneta Kimber-Trojnar, Jolanta Patro-Małysza, Anna Olszewska, Tomasz Zaborowski, Teresa Małecka-Massalska

Journal Name: Current Pharmaceutical Biotechnology

Volume 17 , Issue 7 , 2016

Become EABM
Become Reviewer


Gestational diabetes mellitus (GDM) is traditionally defined as hyperglycemia first detected in pregnancy. The risk of GDM is much higher among obese women than in their lean counterparts. An excess of adipose tissue leads to immune and inflammatory responses of both white adipose tissue and the placenta, contributing to systemic inflammation. Although the significance of both obesity and inflammation is relatively well characterized in GDM, the molecular mechanisms involved are not fully defined and require further study. In recent years huge progress has been made in identifying the intracellular signaling pathways involved in the pathophysiology of GDM. However, currently available data regarding inflammation and obesity in women with GDM are still conflicting or incomplete. We discuss selected aspects of the problem and propose future directions for research in the hope of achieving a better understanding of the disease. In particular, this review highlights recent studies exploring molecular alterations related to insulin resistance, inflammation of the adipose tissue and the placenta, lipotoxicity or endotoxemia.

Keywords: Cytokines, gestational diabetes mellitus, inflammation, insulin resistance, lipotoxicity, obesity.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [603 - 613]
Pages: 11
DOI: 10.2174/1389201017666160127105926
Price: $65

Article Metrics

PDF: 53